Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (KCT0011353) titled 'COmparisoN of Anti-ThrombotiC Treatments Between Aspirin and Warfarin During InitiaL Six Months After Bioprosthetic Heart ValvE Replacement' on Dec. 19, 2025.
Study Type: Interventional Study
Study Design:
Primary Purpose : Treatment, Intervention Model : Parallel, Blinding/Masking : Open, Allocation : RCT
Primary Sponsor: Asan Medical Center
Condition:
Diseases of the circulatory system
Intervention:
Drug : aspirin : 100mg 1 tablet once daily for 6 months
Vitamin K antagonist(warfarin) : Maintain an INR of 2.0 to 3.0 for 6 months...
Recruitment Status: Not Recruiting
Phase: Phase4
Date of First Enrollme...